What is the diagnostic test for pertussis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 14, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Diagnostic Testing for Pertussis

The CDC recommends collecting a nasopharyngeal aspirate or Dacron swab for culture as the gold standard diagnostic test, with PCR endorsed as an additional option when the clinical case definition is met (cough >2 weeks with paroxysms, inspiratory "whoop," or post-tussive vomiting). 1

Clinical Case Definition

Before ordering diagnostic tests, confirm the patient meets clinical criteria:

  • Acute cough persisting >2 weeks accompanied by at least one of the following: 2, 1
    • Paroxysms of coughing
    • Post-tussive vomiting
    • Inspiratory whooping sound

Diagnostic Testing Algorithm

First-Line Testing: Culture

  • Collect nasopharyngeal aspirate or use a Dacron swab (not cotton) of the nasopharynx for culture 2, 1
  • Culture is 100% specific and remains the only certain way to make a definitive diagnosis 2, 1
  • Critical limitation: sensitivity is only 30-60% in practice and drops to 1-3% after 3 weeks of cough 1
  • Sensitivity decreases with: 1
    • Duration >2 weeks of cough
    • Prior antimicrobial treatment
    • Previous pertussis vaccination
  • Culture requires 1-2 weeks for definitive results 1
  • Despite limitations, culture remains essential for antimicrobial susceptibility testing and molecular subtyping 1

PCR Testing

  • The CDC endorses PCR only when the clinical case definition is also met (>2 weeks cough with characteristic features) 1
  • PCR has significantly higher sensitivity (80-100%) compared to culture 2, 1
  • PCR is 2-3 times more likely than culture to detect B. pertussis when classic symptoms are present 1
  • PCR provides shorter turnaround time than culture 1
  • Important caveat: The 2006 ACCP guidelines rated PCR as grade I (conflicting benefit) due to lack of standardized, validated techniques at that time 2, but the CDC now endorses PCR when clinical criteria are met 1
  • PCR remains positive 1-7 days longer than culture after starting erythromycin treatment 3

Timing Considerations

  • Begin testing as early as possible in the illness course 1
  • Optimal window: within first 2-3 weeks of cough onset 2, 1
  • After 3 weeks, culture sensitivity drops dramatically to 1-3% 1
  • PCR maintains better sensitivity than culture in later stages 4, 5

Serologic Testing (Not Recommended for Routine Diagnosis)

  • The CDC does not endorse single-sample serologic testing for routine diagnostic use 6
  • Serology cannot differentiate between recent infection, remote infection, or vaccination response 6
  • No FDA-licensed serologic assays exist for routine pertussis diagnosis in the United States 6
  • If serology is used, paired sera (acute and convalescent) showing fourfold rise in IgG or IgA antibodies to pertussis toxin or filamentous hemagglutinin can confirm infection retrospectively 2, 6
  • First sample should be taken within 2 weeks of cough onset, second sample 3-4 weeks later 2
  • Paired sera have 99% specificity but only 63% sensitivity 2

Confirmed Diagnosis Criteria

A confirmed case requires one of the following: 2, 1

  • Isolation of B. pertussis from nasopharyngeal culture, OR
  • Clinical case with PCR confirmation, OR
  • Clinical case with epidemiologic linkage to a confirmed case

Critical Treatment Considerations

  • Do not delay treatment while awaiting test results 1
  • Early treatment (within first 2 weeks) will rapidly clear B. pertussis from the nasopharynx and decrease coughing paroxysms 1
  • Isolate patients for 5 days after starting antibiotic therapy 1
  • Recommended treatment: erythromycin 40-50 mg/kg/day in children, 1-2 g/day in adults for 2 weeks 2

Common Pitfalls to Avoid

  • Avoid relying solely on culture after 2-3 weeks of symptoms - sensitivity becomes extremely poor 1
  • Do not use cotton swabs - use Dacron or polyester swabs for optimal specimen collection 2
  • Do not order single-sample serology for acute diagnosis - it cannot distinguish infection from vaccination 6
  • Do not wait for test results to initiate treatment in clinically suspected cases 1
  • Avoid PCR testing in patients who don't meet clinical criteria - CDC endorses PCR only when clinical case definition is met 1

References

Guideline

Diagnostic Testing for Pertussis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Interpretation of B. pertussis IgG Antibody Results

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.